Resultados Tardíos de Pacientes Sometidos a Implante de Stents Farmacológicos del Registro SAFIRA


Daniel de Oliveira Neto Barbosa, Julio Flavio Meirelles Marchini, Mohamad Said Ghandour, Bruno Veras Bezerra, Salvador André Bavaresco Cristovão, Nadia Mendonça Carnieto, Eduardo Erudilho, Adnan Ali Salman, Maria Fernanda Zuliani Mauro, José Armando

More articles by this author

Riesgos de la Radiación X y la Importancia de la Protección Radiológica en la Cardiología Intervencionista: Una Revisión Sistemática

Fernando Leyton, Lucia Canevaro, Adriano Dourado, Helio Castello, Alexandre Bacelar, Marcus Teixeira Navarro, Eliseo Vañó, Maria do Socorro Nogueira, Wilson Otto Batista, Tânia A....

Técnicas y Tácticas en el Tratamiento Endovascular del Aneurisma de la Arteria Renal

Keillyanne Jaira Ferreira Barros, Patrick Bastos Metzger, Fabio Henrique Rossi, Thiago Osawa Rodrigues, Samuel Martins Moreira, Ana Claudia Gomes Petisco, Nilo Mitsuru Izukawa, Antonio...

Cierre Percutáneo de Fístula Aorto-coronaria Venosa Adquirida Luego de Revascularización Miocárdica: Experiencia Inicial con Plug Vascular Auto Expandible de Nitinol

Manuel Pereira Marques Gomes Jr., Ricardo Peressoni Faraco, Manfredo Kenji Naritomi, Elisabeth Tomoko Takitani, José Victor Kairiyama, Cláudia Maria Rodrigues Alves

¿La Inhibición de la Vía Final Común de la Agregación Plaquetaria Reduce el Fenómeno de no-reflow Durante la Intervención Coronaria Percutánea Primaria?...

Igor Matos Lago, J. Antonio Marin-Neto, Moysés de Oliveira Lima-Filho, Antonio Pazin Filho, Geraldo Luiz Figueiredo, Jorge Luis Haddad, Roberto Botelho, Ricardo Barbosa, Ulisses...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SAFE-PROTECT at 12 Months: AnchorMan vs. Watchman for Left Atrial Appendage Closure

Percutaneous left atrial appendage (LAA) closure is an alternative therapeutic strategy for reducing the risk of stroke in patients with atrial fibrillation (AF). Randomized...

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...